314 related articles for article (PubMed ID: 24928858)
21. p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells.
Wang B; Li D; Kovalchuk O
Cell Cycle; 2013 Jul; 12(13):2073-83. PubMed ID: 23759592
[TBL] [Abstract][Full Text] [Related]
22. Promoter-specific p53-dependent histone acetylation following DNA damage.
Kaeser MD; Iggo RD
Oncogene; 2004 May; 23(22):4007-13. PubMed ID: 15007388
[TBL] [Abstract][Full Text] [Related]
23. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.
Ou YH; Chung PH; Sun TP; Shieh SY
Mol Biol Cell; 2005 Apr; 16(4):1684-95. PubMed ID: 15659650
[TBL] [Abstract][Full Text] [Related]
24. Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity.
Overstreet JM; Samarakoon R; Meldrum KK; Higgins PJ
Cell Signal; 2014 Jul; 26(7):1427-36. PubMed ID: 24613410
[TBL] [Abstract][Full Text] [Related]
25. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.
Ljungman M; O'Hagan HM; Paulsen MT
Oncogene; 2001 Sep; 20(42):5964-71. PubMed ID: 11593403
[TBL] [Abstract][Full Text] [Related]
26. WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
Chang NS; Doherty J; Ensign A; Schultz L; Hsu LJ; Hong Q
J Biol Chem; 2005 Dec; 280(52):43100-8. PubMed ID: 16219768
[TBL] [Abstract][Full Text] [Related]
27. Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation.
Ma T; Yamada S; Ichwan SJ; Iseki S; Ohtani K; Otsu M; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(3):931-7. PubMed ID: 22166212
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity.
Turenne GA; Price BD
BMC Cell Biol; 2001; 2():12. PubMed ID: 11483158
[TBL] [Abstract][Full Text] [Related]
29. Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin.
Zajkowicz A; Gdowicz-Kłosok A; Krześniak M; Ścieglińska D; Rusin M
Cell Signal; 2015 Sep; 27(9):1677-87. PubMed ID: 25989210
[TBL] [Abstract][Full Text] [Related]
30. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20.
Kishi H; Nakagawa K; Matsumoto M; Suga M; Ando M; Taya Y; Yamaizumi M
J Biol Chem; 2001 Oct; 276(42):39115-22. PubMed ID: 11495913
[TBL] [Abstract][Full Text] [Related]
31. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
32. P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells.
Ding H; Duan W; Zhu WG; Ju R; Srinivasan K; Otterson GA; Villalona-Calero MA
Biochem Biophys Res Commun; 2003 Jun; 305(4):950-6. PubMed ID: 12767922
[TBL] [Abstract][Full Text] [Related]
33. Insights into selective activation of p53 DNA binding by c-Abl.
Wei G; Li AG; Liu X
J Biol Chem; 2005 Apr; 280(13):12271-8. PubMed ID: 15661746
[TBL] [Abstract][Full Text] [Related]
34. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
35. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.
Amano T; Nakamizo A; Mishra SK; Gumin J; Shinojima N; Sawaya R; Lang FF
J Neurooncol; 2009 May; 92(3):357-71. PubMed ID: 19357962
[TBL] [Abstract][Full Text] [Related]
37. p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20.
Jabbur JR; Zhang W
Cancer Biol Ther; 2002; 1(3):277-83. PubMed ID: 12432277
[TBL] [Abstract][Full Text] [Related]
38. ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.
Nghiem P; Park PK; Kim Ys YS; Desai BN; Schreiber SL
J Biol Chem; 2002 Feb; 277(6):4428-34. PubMed ID: 11711532
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.
Thompson T; Tovar C; Yang H; Carvajal D; Vu BT; Xu Q; Wahl GM; Heimbrook DC; Vassilev LT
J Biol Chem; 2004 Dec; 279(51):53015-22. PubMed ID: 15471885
[TBL] [Abstract][Full Text] [Related]
40. p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation.
Tritarelli A; Oricchio E; Ciciarello M; Mangiacasale R; Palena A; Lavia P; Soddu S; Cundari E
Mol Biol Cell; 2004 Aug; 15(8):3751-7. PubMed ID: 15181149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
